Rivaroxaban Impurity 35 | CAS 89283-13-6 - Request Quote
Rivaroxaban Impurity 35
| SZ CAT No: | SZ-R017063 |
| CAS No | 89283-13-6 |
| Mol.F. | C5HCl3OS |
| Mol.Wt. | 215.5 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rivaroxaban Impurity 35 is chemically 4,5-dichlorothiophene-2-carbonyl chloride. Rivaroxaban Impurity 35 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 35 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 89283-13-6
Purchase 89283-13-6
Order 89283-13-6
Enquire 89283-13-6
price of 89283-13-6
89283-13-6 Supplier
89283-13-6 Manufacturer
89283-13-6 Exporter
buy high quality Rivaroxaban Impurity 35
Purchase Rivaroxaban Impurity 35
Rivaroxaban Impurity 35 suppliers
Rivaroxaban Impurity 35 manufacturers
Rivaroxaban Impurity 35 price
Order Rivaroxaban Impurity 35
Enquire Rivaroxaban Impurity 35
Rivaroxaban Impurity 35 cost
Rivaroxaban Impurity 35 Supplier
Rivaroxaban Impurity 35 Distributor
Rivaroxaban Impurity 35 for Method Validation
Rivaroxaban Reference Standard
Rivaroxaban Impurity 35 for ANDA Filing
Rivaroxaban Impurity 35 for Forced Degradation Studies
Rivaroxaban Impurity 35 Identification Standards
Rivaroxaban Impurity 35 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


